
Novo Nordisk CEO Talks Weight Loss Drug Supply
Bloomberg Talks
Exploring Long-Term Use and Administration Routes of Weight Loss Drugs
Exploring the debate around the continued use of weight loss drugs like GLP-1s, questioning if they are permanent solutions or if discontinuation is feasible post-achievement of weight loss goals. The chapter also touches on personalized medicine, varying patient needs, and the evolving landscape of medication administration from injectables to oral pills.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.